Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
3. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma
4. Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program
5. Outcome of LR-3 and LR-4 observations without arterial phase hyperenhancement at Gd-EOB-DTPA-enhanced MRI follow-up
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical impact of MRI on indeterminate findings on contrast-enhanced CT suspicious of HCC;Scandinavian Journal of Gastroenterology;2024-07-26
2. The Rising Threat of Liver Cancer in Patients with Cirrhosis: Are Indeterminate Liver Nodules Cause for Concern? Real-world, long-term follow-up data;2024-07-26
3. Optimizing LI-RADS: ancillary features screened from LR-3/4 categories can improve the diagnosis of HCC on MRI;BMC Gastroenterology;2024-03-21
4. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis;Clinical Gastroenterology and Hepatology;2024-02
5. Up-to-Date Role of Liver Imaging Reporting and Data System in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3